2-169083573-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001376924.1(DHRS9):āc.558C>Gā(p.Phe186Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 32)
Exomes š: 0.000014 ( 0 hom. )
Consequence
DHRS9
NM_001376924.1 missense
NM_001376924.1 missense
Scores
5
11
3
Clinical Significance
Conservation
PhyloP100: 0.560
Genes affected
DHRS9 (HGNC:16888): (dehydrogenase/reductase 9) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. This protein demonstrates oxidoreductase activity toward hydroxysteroids and is able to convert 3-alpha-tetrahydroprogesterone to dihydroxyprogesterone and 3-alpha-androstanediol to dihydroxyprogesterone in the cytoplasm, and may additionally function as a transcriptional repressor in the nucleus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.826
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHRS9 | NM_001376924.1 | c.558C>G | p.Phe186Leu | missense_variant | 3/5 | ENST00000674881.1 | NP_001363853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DHRS9 | ENST00000674881.1 | c.558C>G | p.Phe186Leu | missense_variant | 3/5 | NM_001376924.1 | ENSP00000502399.1 | |||
DHRS9 | ENST00000602501.5 | c.558C>G | p.Phe186Leu | missense_variant | 6/8 | 1 | ENSP00000473337.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152124Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
21
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250884Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135584
GnomAD3 exomes
AF:
AC:
8
AN:
250884
Hom.:
AF XY:
AC XY:
3
AN XY:
135584
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461684Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727124
GnomAD4 exome
AF:
AC:
20
AN:
1461684
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
727124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74308
GnomAD4 genome
AF:
AC:
21
AN:
152124
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.558C>G (p.F186L) alteration is located in exon 6 (coding exon 2) of the DHRS9 gene. This alteration results from a C to G substitution at nucleotide position 558, causing the phenylalanine (F) at amino acid position 186 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;D;.;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D;.;D;.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;N;.;N;.;N;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;D;D;D;D;D
REVEL
Uncertain
Sift
Pathogenic
.;D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;T;D;D
Polyphen
D;D;.;D;.;D;D
Vest4
MutPred
Gain of disorder (P = 0.1278);Gain of disorder (P = 0.1278);.;Gain of disorder (P = 0.1278);.;Gain of disorder (P = 0.1278);Gain of disorder (P = 0.1278);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at